STIVARGA (regorafenib) Patient Assistance Program
Don’t let the high cost of advanced cancer therapy stand between you and the treatment you need. We help eligible patients access Stivarga (regorafenib) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Stivarga (regorafenib) is FDA-approved for metastatic colorectal cancer that has progressed after prior therapy, advanced gastrointestinal stromal tumors (GIST) after imatinib and sunitinib, and previously-treated hepatocellular carcinoma. It is taken on a 21-days-on, 7-days-off cycle.
- Without assistance, the retail cost commonly runs $8,000–$10,000 per 28-day cycle, with list pricing above $20,000 for an 84-tablet supply. Annual costs commonly land between $96,000 and $120,000.
- Through AffordMyPrescriptions, qualifying patients can access Stivarga for a flat $69.95 per month — our advocacy team manages the entire enrollment, refills, and renewal process.
- There is no generic version of Stivarga available in the U.S. as of 2026.
What is Stivarga Prescription Assistance Program?
TThe Stivarga Prescription Assistance Program is a manufacturer-sponsored initiative that provides Stivarga at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for uninsured and underinsured individuals, as well as Medicare Part D beneficiaries who cannot afford their specialty oncology therapy.
Navigating the program on your own means dealing with eligibility verification, oncology-team coordination, complex documentation, specialty pharmacy logistics, and renewal deadlines — all while managing advanced cancer therapy that depends on uninterrupted access on a 21-days-on, 7-days-off cycle.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment, from initial application through refill coordination and annual re-certification — so you focus on your treatment, not paperwork.
Pharmacy Price Comparison
- Without assistance, Stivarga costs roughly $8,000–$10,000 per 28-day cycle at retail pharmacies. Discount coupons offer little relief at this price level. A Patient Assistance Program is the meaningful path forward — if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$9,800.00 | Save ~$9,730/mo |
| CVS Pharmacy | ~$9,950.00 | Save ~$9,880/mo |
| Walmart | ~$8,800.00 | Save ~$8,730/mo |
| Costco | ~$8,400.00 | Save ~$8,330/mo |
| Kroger | ~$8,600.00 | Save ~$8,530/mo |
*Retail prices are estimates based on public data and vary by pharmacy. Coupon prices from GoodRx and SingleCare as of April 2026. Afford My Prescriptions Advocacy Service bypasses retail pricing by using drug manufacturer programs to secure your medication for you—independent of dosage or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Stivarga Prescription Program?
The Patient Assistance Program is free to apply for and provides medication at no medication cost if approved. But the process involves detailed applications, prescriber coordination, specialty pharmacy logistics, and ongoing renewal management especially complex for biologic injectables like Betaseron. Our $69.95/month service covers full advocacy: applications, doctor coordination, documentation, refill management, autoinjector device coordination, and annual re-enrollment — so you focus on your health, not paperwork.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Stivarga:
Limitations of Coupons
Prices fluctuate — savings aren’t guaranteed month-to-month
Copay accumulators may prevent savings from counting toward your deductible
Coupon cards expire and require constant renewal
Still $8,000–$10,000 per month even with the best discount
Cannot be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
Medication supplied directly through the assistance program
We manage all paperwork, refills, autoinjector coordination, and annual renewals
Medicare Part D patients accepted
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Stivarga assistance.
- You are a U.S. citizen or legal resident
- You Have A Valid Stivarga Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured Or Underinsured And Cannot Afford Your Medication
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Understanding Stivarga:
Stivarga (regorafenib) is an oral specialty oncology medicine used to treat metastatic colorectal cancer that has progressed after prior therapy, advanced gastrointestinal stromal tumors (GIST) after imatinib and sunitinib, and previously-treated hepatocellular carcinoma. It belongs to a class of cancer drugs called multi-kinase inhibitors and is taken on a 21-days-on, 7-days-off cycle
How It Works:
Stivarga is a multi-kinase inhibitor that works by blocking several proteins responsible for cancer cell growth and the development of supporting blood vessels. By interfering with these signals simultaneously, it slows down disease progression in tumors that have resisted other treatments. Because it impacts multiple pathways, it targets both the cancer cells and the environment that helps them survive.
Form and Use:
The standard dosage is 160 mg, taken as four tablets once daily for the first 21 days of a 28-day cycle, followed by a seven-day break. To ensure proper absorption, the medication should be taken with a low-fat breakfast containing less than 30% fat. Oncology teams may adjust this daily dose if necessary to help patients better manage side effects.
Generic Availability:
As of 2026, there is no FDA-approved generic version of Stivarga available in the United States. Current patent and exclusivity protections remain in effect, and no official date for a generic launch has been announced. While other treatment paths may be available for the same conditions, any decisions regarding alternative therapies are handled by a patient’s oncology team.
Warnings:
Stivarga carries a boxed warning for potential liver injury, which can be severe or fatal, requiring regular liver-function tests before and during treatment. Common side effects include fatigue, high blood pressure, and hand-foot skin reactions. It is essential to follow the specific 21-days-on, 7-days-off schedule exactly and report any symptoms to your medical team immediately.
FAQ (Frequently Asked Questions)
How Much Does Stivarga Cost Without Insurance?
The retail price commonly runs $8,000–$10,000 per 28-day cycle, with list pricing above $20,000 for an 84-tablet supply. Coupon discounts at major pharmacies exist but are modest because the underlying price is so high. Through AffordMyPrescriptions, qualifying patients receive Stivarga at no medication cost — our $69.95 monthly fee covers full advocacy and program management.
Is This The Same Stivarga I'd Get At A Pharmacy?
Yes. The Betaseron supplied through the assistance program is the identical FDA-approved interferon beta-1b you would receive at a retail pharmacy — same active ingredient, same dosage forms, same autoinjector device, same packaging. It is sourced directly through the manufacture’s program.
What Is The 21-Days-On, 7-Days-Off Cycle?
Stivarga is taken every day for the first three weeks of each 28-day cycle and then paused for one week before starting the next cycle. This rest week is part of how the medication is designed to be tolerated over multiple cycles. Skipping doses outside this schedule, or taking extra doses, can affect how well the medication works and how it is tolerated.
Is There A Generic Version Of Stivarga?
No. There is no generic version of Stivarga available in the U.S. as of 2026, and a generic launch date has not been publicly confirmed. Other cancer treatment paths may exist depending on your tumor type and prior therapy — those choices belong with your oncology team.
Can I Get Stivarga Through The PAP If I Have Medicare?
Yes. Medicare Part D beneficiaries can typically qualify for Stivarga Patient Assistance, especially if you face specialty-tier copays you cannot afford. The manufacturer’s commercial copay savings program ($0 per fill, up to ~$25,000/year) is reserved for commercially insured patients only — but the underlying PAP supports Medicare patients who meet income criteria.
What If My Application Is Denied?
If your initial application is denied, we explore alternative savings paths on your behalf — including independent oncology-focused foundations such as the PAN Foundation or HealthWell Foundation that periodically open colorectal, GIST, and liver cancer funds, the manufacturer’s copay savings program if you have commercial insurance, or asking your oncology team whether a different treatment on a more accessible assistance pathway would be appropriate. If we cannot find a path to medication access, you will not be charged our service fee.
Take Control of Your Medication Costs
If you are struggling with the high cost of Stivarga, our team may be able to help you access assistance programs designed to make advanced cancer therapy affordable. Check your eligibility today and take the first step toward predictable, sustainable treatment.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.